[250 Pages Report] The precision cancer imaging system market is expected to register a CAGR of 12% during the forecast period, up from US$ 67.8 Bn in 2022 to reach a valuation of US$ 210.58 Bn by 2032.
Sales of precision cancer imaging system is expected to rise due to the rising awareness among the patients relating to molecular foundation of cancer and rising preference for personalized treatments.
Attributes | Details |
---|---|
Precision Cancer Imaging Market Value (2022) | US$ 67.8 Bn |
Precision Cancer Imaging Market Projected Value (2022-2032) | US$ 210.58 Bn |
Precision Cancer Imaging Market CAGR (2022-2032) | 12% |
The increasing occurrence of various types of cancer, such as breast, lung, prostate, and colorectal cancer, is the key reason driving the growth of the precision cancer imaging market share. A number of evolving technologies in Precision Cancer Imaging, such as clinical decision-making software, sensors, three-dimensional printing, deep learning, and artificial intelligence, are likely to boost the sales of precision cancer imaging systems.
The cost is a major issue affecting the sales of precision cancer imaging system. Precision Cancer Imaging may further overload many healthcare systems that are already under severe financial restrictions.
The demand for precision cancer imaging system is rising as it is a great procedure that is impeding the patient's access to treatment. The latest targeted pharmaceuticals that are introduced into the precision cancer imaging market are so exorbitantly costly that patients cannot afford them.
The demand for precision cancer imaging system is increasing due to the rising preference by physicians, healthcare systems, pharmaceutical agencies, patients, and the government, which is one of the most expected factors in the precision cancer imaging market's growth.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The demand for precision cancer imaging system is rising as they play a significant role in cancer detection. Furthermore, the sales of precision cancer imaging system are anticipated to grow as they provide a thorough perception of the exact location and extent of the disease.
Precision cancer imaging is a strategy for diagnosing scientific illnesses that take individual variations in hereditary and environmental factors into account. As a result, the demand for precision cancer imaging systems rises. A precision cancer imaging system provides precise information on structural or cancer-related changes.
The sales of precision cancer imaging system are growing as they aid in the discovery of tumours and also in the evaluation of therapeutic and post-therapeutic modifications, consequences of treatments, and follow-up for the early detection of recurrence. These factors combined aid the growth of the global precision cancer imaging market share.
Furthermore, an unexpected spike in pandemic cases has raised the demand for COVID-19 diagnostic techniques and products, resulting in increased demand for precision cancer imaging systems.
According to the World Health Organization (WHO), COVID-19 will affect 163,312,429 persons worldwide in May 2021. Such a rapid increase in instances on a daily basis has accelerated the sales of precision cancer imaging systems and the use of modern diagnostic solutions to offer patients early treatment.
The demand for precision cancer imaging system is anticipated to witness growth. Furthermore, screening, early diagnosis, guiding treatment, evaluating response to therapy, and estimating the risk of disease recurrence, plays a key role in rising sales of precision cancer imaging system.
Another prospective aspect leading to the growth of the precision cancer imaging market is the increasing incidence of various types of cancer and active research and development activities dedicated to the non-stop innovation of imaging modalities. The precision cancer imaging market share is growing at an exponential rate.
Due to its established health care infrastructure, awareness of early illness diagnosis, and high healthcare spending, North America accounted for a significant proportion of the precision cancer imaging market.
The demand for precision cancer imaging system is expected to grow significantly in Asia-Pacific due to the existence of emerging markets such as India and China, as well as growing medical tourism due to low prognostic prices and hospital modernization in these countries.
Furthermore, due to the vast population pool in the area, gadget manufacturers are investing heavily in emerging markets. Germany dominates the precision cancer imaging market in Europe. South Africa is regarded as one of the most important markets in the Middle East and Africa because of the high frequency of various diseases.
Some of the key players in precision cancer imaging market are GE Healthcare (U.S.), Hologic, Inc. (U.S.), Koninklijke Philips N.V. (Philips Healthcare) (Netherlands), Hitachi, Ltd. (Hitachi Medical Corporation) (Japan), Shimadzu Corporation (Japan), Toshiba Corporation (Japan), Siemens AG (Germany), Fujifilm Holdings Corporation (Japan), Carestream Health (U.S.), Esaote SpA (Italy) and others.
Report Attribute | Details |
---|---|
Growth rate | CAGR of 12% from 2022 to 2032 |
Base year for estimation | 2021 |
Historical data | 2015 - 2020 |
Forecast period | 2022 - 2032 |
Quantitative units | Revenue in USD Million and CAGR from 2022 to 2032 |
Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis, |
Segments covered | Modality, end user, region |
Regional scope | North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand |
Country scope | U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa |
Key companies profiled | GE Healthcare (U.S.), Hologic, Inc. (U.S.), Koninklijke Philips N.V. (Philips Healthcare) (Netherlands), Hitachi, Ltd. (Hitachi Medical Corporation) (Japan), Shimadzu Corporation (Japan), Toshiba Corporation (Japan), Siemens AG (Germany), Fujifilm Holdings Corporation (Japan), Carestream Health (U.S.), Esaote SpA (Italy) and others. |
Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The precision cancer imaging market is predicted/forecasted to register a CAGR of P% during the forecast period.
Key players holding substantial precision cancer imaging market share include GE Healthcare (U.S.), Hologic, Inc. (U.S.), Koninklijke Philips N.V. (Philips Healthcare) (Netherlands), Hitachi, Ltd. (Hitachi Medical Corporation) (Japan), Shimadzu Corporation (Japan), Toshiba Corporation (Japan), Siemens AG (Germany), Fujifilm Holdings Corporation (Japan), Carestream Health (U.S.), Esaote SpA (Italy).
As per the analysis, the Precision Cancer Imaging Market share is likely to be US$ 210.58 Bn by 2032.
Demand for precision cancer imaging is likely to rise due to the rising awareness among the patients relating to molecular foundation of cancer and rising preference for personalized treatments
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Precision Cancer Imaging Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Precision Cancer Imaging Market Analysis 2017-2021 and Forecast 2022-2032, By Imaging Technique 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) Analysis By Imaging Technique, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Imaging Technique, 2022-2032 5.3.1. Magnetic Resonance Imaging 5.3.2. Molecular Imaging 5.3.3. Nuclear Medicine Scans 5.4. Y-o-Y Growth Trend Analysis By Imaging Technique, 2017-2021 5.5. Absolute $ Opportunity Analysis By Imaging Technique, 2022-2032 Deep-dive segmentation will be available in the sample on request 6. Global Precision Cancer Imaging Market Analysis 2017-2021 and Forecast 2022-2032, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032 6.3.1. Hospitals 6.3.2. Research Laboratories 6.3.3. Diagnostic Laboratories 6.3.4. Academic Research Institutes 6.3.5. Specialty Clinics 6.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021 6.5. Absolute $ Opportunity Analysis By End User, 2022-2032 Deep-dive segmentation will be available in the sample on request 7. Global Precision Cancer Imaging Market Analysis 2017-2021 and Forecast 2022-2032, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021 7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. East Asia 7.3.5. South Asia & Pacific 7.3.6. MEA 7.4. Market Attractiveness Analysis By Region 8. North America Precision Cancer Imaging Market Analysis 2017-2021 and Forecast 2022-2032, By Country 8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 8.2.1. By Country 8.2.1.1. U.S. 8.2.1.2. Canada 8.2.2. By Imaging Technique 8.2.3. By End User 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Imaging Technique 8.3.3. By End User 8.4. Key Takeaways 9. Latin America Precision Cancer Imaging Market Analysis 2017-2021 and Forecast 2022-2032, By Country 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Imaging Technique 9.2.3. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Imaging Technique 9.3.3. By End User 9.4. Key Takeaways 10. Europe Precision Cancer Imaging Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. U.K. 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Europe 10.2.2. By Imaging Technique 10.2.3. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Imaging Technique 10.3.3. By End User 10.4. Key Takeaways 11. East Asia Precision Cancer Imaging Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. China 11.2.1.2. Japan 11.2.1.3. South Korea 11.2.2. By Imaging Technique 11.2.3. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Imaging Technique 11.3.3. By End User 11.4. Key Takeaways 12. South Asia & Pacific Precision Cancer Imaging Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Thailand 12.2.1.3. Indonesia 12.2.1.4. Malaysia 12.2.1.5. Singapore 12.2.1.6. Australia 12.2.1.7. New Zealand 12.2.1.8. Rest of South Asia & Pacific 12.2.2. By Imaging Technique 12.2.3. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Imaging Technique 12.3.3. By End User 12.4. Key Takeaways 13. MEA Precision Cancer Imaging Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. GCC Countries 13.2.1.2. South Africa 13.2.1.3. Israel 13.2.1.4. Rest of MEA 13.2.2. By Imaging Technique 13.2.3. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Imaging Technique 13.3.3. By End User 13.4. Key Takeaways 14. Key Countries Precision Cancer Imaging Market Analysis 14.1. U.S. 14.1.1. Pricing Analysis 14.1.2. Market Share Analysis, 2021 14.1.2.1. By Imaging Technique 14.1.2.2. By End User 14.2. Canada 14.2.1. Pricing Analysis 14.2.2. Market Share Analysis, 2021 14.2.2.1. By Imaging Technique 14.2.2.2. By End User 14.3. Brazil 14.3.1. Pricing Analysis 14.3.2. Market Share Analysis, 2021 14.3.2.1. By Imaging Technique 14.3.2.2. By End User 14.4. Mexico 14.4.1. Pricing Analysis 14.4.2. Market Share Analysis, 2021 14.4.2.1. By Imaging Technique 14.4.2.2. By End User 14.5. Germany 14.5.1. Pricing Analysis 14.5.2. Market Share Analysis, 2021 14.5.2.1. By Imaging Technique 14.5.2.2. By End User 14.6. U.K. 14.6.1. Pricing Analysis 14.6.2. Market Share Analysis, 2021 14.6.2.1. By Imaging Technique 14.6.2.2. By End User 14.7. France 14.7.1. Pricing Analysis 14.7.2. Market Share Analysis, 2021 14.7.2.1. By Imaging Technique 14.7.2.2. By End User 14.8. Spain 14.8.1. Pricing Analysis 14.8.2. Market Share Analysis, 2021 14.8.2.1. By Imaging Technique 14.8.2.2. By End User 14.9. Italy 14.9.1. Pricing Analysis 14.9.2. Market Share Analysis, 2021 14.9.2.1. By Imaging Technique 14.9.2.2. By End User 14.10. China 14.10.1. Pricing Analysis 14.10.2. Market Share Analysis, 2021 14.10.2.1. By Imaging Technique 14.10.2.2. By End User 14.11. Japan 14.11.1. Pricing Analysis 14.11.2. Market Share Analysis, 2021 14.11.2.1. By Imaging Technique 14.11.2.2. By End User 14.12. South Korea 14.12.1. Pricing Analysis 14.12.2. Market Share Analysis, 2021 14.12.2.1. By Imaging Technique 14.12.2.2. By End User 14.13. India 14.13.1. Pricing Analysis 14.13.2. Market Share Analysis, 2021 14.13.2.1. By Imaging Technique 14.13.2.2. By End User 14.14. Thailand 14.14.1. Pricing Analysis 14.14.2. Market Share Analysis, 2021 14.14.2.1. By Imaging Technique 14.14.2.2. By End User 14.15. Indonesia 14.15.1. Pricing Analysis 14.15.2. Market Share Analysis, 2021 14.15.2.1. By Imaging Technique 14.15.2.2. By End User 14.16. Malaysia 14.16.1. Pricing Analysis 14.16.2. Market Share Analysis, 2021 14.16.2.1. By Imaging Technique 14.16.2.2. By End User 14.17. Singapore 14.17.1. Pricing Analysis 14.17.2. Market Share Analysis, 2021 14.17.2.1. By Imaging Technique 14.17.2.2. By End User 14.18. Australia 14.18.1. Pricing Analysis 14.18.2. Market Share Analysis, 2021 14.18.2.1. By Imaging Technique 14.18.2.2. By End User 14.19. New Zealand 14.19.1. Pricing Analysis 14.19.2. Market Share Analysis, 2021 14.19.2.1. By Imaging Technique 14.19.2.2. By End User 14.20. GCC Countries 14.20.1. Pricing Analysis 14.20.2. Market Share Analysis, 2021 14.20.2.1. By Imaging Technique 14.20.2.2. By End User 14.21. South Africa 14.21.1. Pricing Analysis 14.21.2. Market Share Analysis, 2021 14.21.2.1. By Imaging Technique 14.21.2.2. By End User 14.22. Israel 14.22.1. Pricing Analysis 14.22.2. Market Share Analysis, 2021 14.22.2.1. By Imaging Technique 14.22.2.2. By End User 15. Market Structure Analysis 15.1. Competition Dashboard 15.2. Competition Benchmarking 15.3. Market Share Analysis of Top Players 15.3.1. By Regional 15.3.2. By Imaging Technique 15.3.3. By End User 16. Competition Analysis 16.1. Competition Deep Dive 16.1.1. General Electric Company 16.1.1.1. Overview 16.1.1.2. Product Portfolio 16.1.1.3. Profitability by Market Segments 16.1.1.4. Sales Footprint 16.1.1.5. Strategy Overview 16.1.1.5.1. Marketing Strategy 16.1.1.5.2. Product Strategy 16.1.1.5.3. Channel Strategy 16.1.2. Koninklijke Philips N.V. 16.1.2.1. Overview 16.1.2.2. Product Portfolio 16.1.2.3. Profitability by Market Segments 16.1.2.4. Sales Footprint 16.1.2.5. Strategy Overview 16.1.2.5.1. Marketing Strategy 16.1.2.5.2. Product Strategy 16.1.2.5.3. Channel Strategy 16.1.3. Siemens AG 16.1.3.1. Overview 16.1.3.2. Product Portfolio 16.1.3.3. Profitability by Market Segments 16.1.3.4. Sales Footprint 16.1.3.5. Strategy Overview 16.1.3.5.1. Marketing Strategy 16.1.3.5.2. Product Strategy 16.1.3.5.3. Channel Strategy 16.1.4. Hologic, Inc. 16.1.4.1. Overview 16.1.4.2. Product Portfolio 16.1.4.3. Profitability by Market Segments 16.1.4.4. Sales Footprint 16.1.4.5. Strategy Overview 16.1.4.5.1. Marketing Strategy 16.1.4.5.2. Product Strategy 16.1.4.5.3. Channel Strategy 16.1.5. Hitachi, Ltd. 16.1.5.1. Overview 16.1.5.2. Product Portfolio 16.1.5.3. Profitability by Market Segments 16.1.5.4. Sales Footprint 16.1.5.5. Strategy Overview 16.1.5.5.1. Marketing Strategy 16.1.5.5.2. Product Strategy 16.1.5.5.3. Channel Strategy 16.1.6. Shimadzu Corporation 16.1.6.1. Overview 16.1.6.2. Product Portfolio 16.1.6.3. Profitability by Market Segments 16.1.6.4. Sales Footprint 16.1.6.5. Strategy Overview 16.1.6.5.1. Marketing Strategy 16.1.6.5.2. Product Strategy 16.1.6.5.3. Channel Strategy 16.1.7. ESAOTE SPA 16.1.7.1. Overview 16.1.7.2. Product Portfolio 16.1.7.3. Profitability by Market Segments 16.1.7.4. Sales Footprint 16.1.7.5. Strategy Overview 16.1.7.5.1. Marketing Strategy 16.1.7.5.2. Product Strategy 16.1.7.5.3. Channel Strategy 16.1.8. Fujifilm Holdings Corporation 16.1.8.1. Overview 16.1.8.2. Product Portfolio 16.1.8.3. Profitability by Market Segments 16.1.8.4. Sales Footprint 16.1.8.5. Strategy Overview 16.1.8.5.1. Marketing Strategy 16.1.8.5.2. Product Strategy 16.1.8.5.3. Channel Strategy 16.1.9. Carestream Health 16.1.9.1. Overview 16.1.9.2. Product Portfolio 16.1.9.3. Profitability by Market Segments 16.1.9.4. Sales Footprint 16.1.9.5. Strategy Overview 16.1.9.5.1. Marketing Strategy 16.1.9.5.2. Product Strategy 16.1.9.5.3. Channel Strategy 17. Assumptions & Acronyms Used 18. Research Methodology
Explore Healthcare Insights
View Reports